Core Laboratories
CLB
187 hedge funds and large institutions have $639M invested in Core Laboratories in 2020 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 59 increasing their positions, 67 reducing their positions, and 34 closing their positions.
84% more call options, than puts
Call options by funds: $2.96M | Put options by funds: $1.6M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.01% less ownership
Funds ownership: 96.09% → 94.08% (-2%)
5% less funds holding
Funds holding: 197 → 187 (-10)
12% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 67
26% less capital invested
Capital invested by funds: $868M → $639M (-$229M)
26% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 34
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
+$25.7M |
| 2 |
AI
Ariel Investments
Chicago,
Illinois
|
+$23M |
| 3 |
EARNEST Partners
Atlanta,
Georgia
|
+$10.6M |
| 4 |
Millennium Management
New York
|
+$6.58M |
| 5 |
AC
AKO Capital
London,
United Kingdom
|
+$2.97M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$19.4M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$15.5M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$12.3M |
| 4 |
HF
HRT Financial
New York
|
-$8.66M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$6.89M |
CLB Hedge Fund Activity: Q3 2020 in Review
187 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q3 2020, worth a combined $639M — down 26% from $868M a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of CLB and 25 opened new positions — a net loss of 9 holders — while 67 trimmed existing stakes and 59 added.
The largest buyer was Fred Alger Management, adding an estimated $25.7M. The largest seller was Goldman Sachs, cutting an estimated $19.4M.
- 187 institutional investors held Core Laboratories (CLB) as of Q3 2020, down from 197 in Q2 2020.
- Funds reported $639M of Core Laboratories stock for Q3 2020, down 26% quarter-over-quarter.
- 25 funds opened new Core Laboratories positions in Q3 2020 and 34 closed out, a net change of -9 holders.
- The largest Core Laboratories buyer in Q3 2020 was Fred Alger Management, an estimated $25.7M added.
- The largest Core Laboratories seller in Q3 2020 was Goldman Sachs, an estimated $19.4M sold.
Based on aggregated 13F filings for Q3 2020.